Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Vi capsular polysaccharide (Vi antigen) is a surface-expressed polysaccharide capsule found in Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid fever in humans. This capsule is a key virulence factor, distinguishing S. Typhi from most other Salmonella serovars. Its primary function is to enhance bacterial survival during infection by evading host immune responses. Expression of the Vi antigen correlates with increased virulence, and it serves as an important diagnostic marker for identifying S. Typhi. The purified Vi capsular polysaccharide is used as an active component in licensed typhoid vaccines.
Target for typhoid vaccines; elicits antibody production to prevent Salmonella Typhi infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella enterica serovar Typhi Vi Capsular Polysaccharide (Vi antigen).